Apdrb Health & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 11-01-2025
- Paid Up Capital ₹ 3.50 M
as on 11-01-2025
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.29 M
as on 11-01-2025
- Revenue 20.75%
(FY 2022)
- Profit 33.76%
(FY 2022)
- Ebitda 87.89%
(FY 2022)
- Net Worth 20.50%
(FY 2022)
- Total Assets 15.63%
(FY 2022)
About Apdrb Health & Research Centre
The Corporate was formerly known as Aprb Health & Research Centre Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.50 M.
The company has closed loans amounting to ₹2.29 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Brajendra Das, Pankaj Kalita, Ranjit Deka, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110AS2001PTC006637
- Company No.
006637
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apdrb Health & Research Centre?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Brajendra Das  | Director | 25-Sep-2001 | Current |
| Pankaj Kalita | Director | 25-Sep-2001 | Current |
| Ranjit Deka | Director | 25-Sep-2001 | Current |
| Arunav Bora | Director | 25-Sep-2001 | Current |
| Dipak Lahkar | Director | 28-Mar-2014 | Current |
Financial Performance of Apdrb Health & Research Centre.
Apdrb Health & Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.75% increase. The company also saw a substantial improvement in profitability, with a 33.76% increase in profit. The company's net worth Soared by an impressive increase of 20.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apdrb Health & Research Centre?
In 2021, Apdrb Health & Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Uco Bank Ltd. Creation Date: 17 Mar 2004 | ₹2.29 M | Satisfied |
How Many Employees Work at Apdrb Health & Research Centre?
Apdrb Health & Research Centre has a workforce of 25 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apdrb Health & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apdrb Health & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
